Back to News
Market Impact: 0.3
Scancell Secures Up To $25 Mln Debt Facility To Fund ISCIB1+ Phase 3
Source: Nasdaq
Healthcare & BiotechCredit & Bond MarketsCompany Fundamentals
Scancell Holdings entered a loan agreement with BlackRock-managed funds and accounts for a debt facility of up to $25 million. The financing provides the biotech company with additional capital and liquidity, though the article does not disclose drawdown terms, pricing, or intended use of proceeds.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
BLK0.15
SCLP0.55
More News
- Scancell Holdings secures $25m financing as it advances melanoma trial
- BlackRock, IFM close in on $25 billion Stack data center deal, Bloomberg News reports
- How Is BlackRock’s AI Trade Evolving Beyond Pioneers of the Tech?
- Here's who is attending the Trump-Xi state dinner
- Oil, Treasury Yields & Inflation Pressure Markets
- US 30-Year Yield Hits Highest Since 2004